Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
CA 2482810 C · Owner: Barsyte, Dalia · Inventors: Rotzinger, Susan; Chewpoy, R. Bradley; Barsyte, Dalia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a novel family of biologically active neuropeptides and the nucleic aid molecules coding for same. The peptides are derived for the Cterminus of the teneurin family peptides (Ten M1-4). These novel peptides referred to as teneurin C-terminal associated peptides (TCAPs) are active in neuronal communication and are implicated in a number of neuropathologies. They are particularly useful in modulating stress responses and anxiety and in the treatment of cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2003 and granted June 10, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.